SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-016987
Filing Date
2020-08-31
Accepted
2020-08-31 13:13:18
Documents
1
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1536
  Complete submission text file 0001493152-20-016987.txt   2950
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address EMPIRE STATE BUILDING 350 5TH AVE., SUITE 7520 NEW YORK NY 10118
Business Address
Benson Stuart M (Reporting) CIK: 0001691372 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36268 | Film No.: 201150862